Atlas Trials

Relapsed and Refractory DLBCL

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed and Refractory DLBCL

RecordFirmDate
Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT07122609)Ruijin Hospital2025-08-05

Track Relapsed and Refractory DLBCL automatically

Every clearance here is in the API, with alerts when new ones post.